IT Verticals
US
@it-verticals
Quick actions
Mounjaro UK
About
Mounjaro UK (tirzepatide) is a weekly injectable medication approved in the UK for weight management in adults with obesity (BMI ≥30) or overweight (BMI 27–29.9) with weight-related health conditions.It works by regulating appetite and improving insulin sensitivity. The Mounjaro UK authorised its use in November 2023, and NICE has approved it for NHS use in England and Wales, with a phased rollout starting in 2025 .
What we do
Industries
Health & Beauty
Where we are
US